相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming
Zhangnan Liu et al.
CELL DEATH & DISEASE (2023)
Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer- Real-World Outcomes From UK Centres
C. Lorimer et al.
CLINICAL ONCOLOGY (2023)
Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics
Lina Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2023)
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells
Yun Zhang et al.
CANCER GENE THERAPY (2022)
Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells
Long He et al.
SCIENCE ADVANCES (2022)
Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma
Yuchan Li et al.
METABOLITES (2022)
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
Nadilly Bonagas et al.
NATURE CANCER (2022)
Oncogenic Ras expression increases cellular formate production
T. Pongnopparat et al.
AMINO ACIDS (2021)
Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification
Thanh H. Nguyen et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism
Albert M. Li et al.
MOLECULAR CANCER RESEARCH (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies
Inigo Landa et al.
CLINICAL CANCER RESEARCH (2019)
Discovery of a Potent, Selective, and Orally Available MTHFD2 Inhibitor (DS18561882) with in Vivo Antitumor Activity
Junya Kawai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs
Denise R. Minton et al.
MOLECULAR CELL (2018)
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Shikha Saini et al.
MOLECULAR CANCER (2018)
Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
Naiyarat Prasongsook et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
Gregory S. Ducker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
One-Carbon Metabolism in Health and Disease
Gregory S. Ducker et al.
CELL METABOLISM (2017)
Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway
Gregory S. Ducker et al.
CELL METABOLISM (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Serine and one-carbon metabolism in cancer
Ming Yang et al.
NATURE REVIEWS CANCER (2016)
Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
Christina A. von Roemeling et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
Dohoon Kim et al.
NATURE (2015)
Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes
Genee Y. Lee et al.
CANCER RESEARCH (2014)
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
Roland Nilsson et al.
NATURE COMMUNICATIONS (2014)
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: A critical re-evaluation including uniform pathologic review
Eric J. Sherman et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors
Valeria G. Antico Arciuch et al.
ONCOTARGET (2011)
Induction Chemotherapy with Weekly Paclitaxel Administration for Anaplastic Thyroid Carcinoma
Takuya Higashiyama et al.
THYROID (2010)
Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS: gelsolin complex
J. W. Keller et al.
ONCOGENE (2007)
Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion
KB Ain et al.
THYROID (2000)